Literature DB >> 23307779

Recognition of self and altered self by T cells in autoimmunity and allergy.

Lei Yin1, Shaodong Dai, Gina Clayton, Wei Gao, Yang Wang, John Kappler, Philippa Marrack.   

Abstract

T cell recognition of foreign peptide antigen and tolerance to self peptides is key to the proper function of the immune system. Usually, in the thymus T cells that recognize self MHC + self peptides are deleted and those with the potential to recognize self MHC + foreign peptides are selected to mature. However there are exceptions to these rules. Autoimmunity and allergy are two of the most common immune diseases that can be related to recognition of self. Many genes work together to lead to autoimmunity. Of those, particular MHC alleles are the most strongly associated, reflecting the key importance of MHC presentation of self peptides in autoimmunity. T cells specific for combinations of self MHC and self peptides may escape thymus deletion, and thus be able to drive autoimmunity, for several reasons: the relevant self peptide may be presented at low abundance in the thymus but at high level in particular peripheral tissues; the relevant self peptide may bind to MHC in an unusual register, not present in the thymus but apparent elsewhere; finally the relevant self peptide may be post translationally modified in a tissue specific fashion. In some types of allergy, the peptide + MHC combination may also be fully derived from self. However the combination in question may be modified by the presence of other ligands, such as small drug molecules or metal ions. Thus these types of allergies may act like the post translationally modified peptides involved some types of autoimmunity.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23307779      PMCID: PMC3951410          DOI: 10.1007/s13238-012-2077-7

Source DB:  PubMed          Journal:  Protein Cell        ISSN: 1674-800X            Impact factor:   14.870


  80 in total

1.  Immune self-reactivity triggered by drug-modified HLA-peptide repertoire.

Authors:  Patricia T Illing; Julian P Vivian; Nadine L Dudek; Lyudmila Kostenko; Zhenjun Chen; Mandvi Bharadwaj; John J Miles; Lars Kjer-Nielsen; Stephanie Gras; Nicholas A Williamson; Scott R Burrows; Anthony W Purcell; Jamie Rossjohn; James McCluskey
Journal:  Nature       Date:  2012-06-28       Impact factor: 49.962

2.  T cell receptor recognition of a 'super-bulged' major histocompatibility complex class I-bound peptide.

Authors:  Fleur E Tynan; Scott R Burrows; Ashley M Buckle; Craig S Clements; Natalie A Borg; John J Miles; Travis Beddoe; James C Whisstock; Matthew C Wilce; Sharon L Silins; Jacqueline M Burrows; Lars Kjer-Nielsen; Lyudmila Kostenko; Anthony W Purcell; James McCluskey; Jamie Rossjohn
Journal:  Nat Immunol       Date:  2005-09-25       Impact factor: 25.606

3.  Evaluation of 19 autoimmune disease-associated loci with rheumatoid arthritis in a Colombian population: evidence for replication and gene-gene interaction.

Authors:  Harshal A Deshmukh; Amit K Maiti; Xana R Kim-Howard; Adriana Rojas-Villarraga; Joel M Guthridge; Juan-Manuel Anaya; Swapan K Nath
Journal:  J Rheumatol       Date:  2011-07-15       Impact factor: 4.666

4.  Structure of a TCR with high affinity for self-antigen reveals basis for escape from negative selection.

Authors:  Yiyuan Yin; Yili Li; Melissa C Kerzic; Roland Martin; Roy A Mariuzza
Journal:  EMBO J       Date:  2011-02-04       Impact factor: 11.598

5.  Clincal, immunologic, and genetic features of an autoimmune lymphoproliferative syndrome associated with abnormal lymphocyte apoptosis.

Authors:  M C Sneller; J Wang; J K Dale; W Strober; L A Middelton; Y Choi; T A Fleisher; M S Lim; E S Jaffe; J M Puck; M J Lenardo; S E Straus
Journal:  Blood       Date:  1997-02-15       Impact factor: 22.113

6.  Chromogranin A is an autoantigen in type 1 diabetes.

Authors:  Brian D Stadinski; Thomas Delong; Nichole Reisdorph; Richard Reisdorph; Roger L Powell; Michael Armstrong; Jon D Piganelli; Gene Barbour; Brenda Bradley; Frances Crawford; Philippa Marrack; Sushil K Mahata; John W Kappler; Kathryn Haskins
Journal:  Nat Immunol       Date:  2010-02-07       Impact factor: 25.606

7.  T-cell-specific deletion of T-cell receptor transgenes allows functional rearrangement of endogenous alpha- and beta-genes.

Authors:  H Blüthmann; P Kisielow; Y Uematsu; M Malissen; P Krimpenfort; A Berns; H von Boehmer; M Steinmetz
Journal:  Nature       Date:  1988-07-14       Impact factor: 49.962

Review 8.  Do MHCII-presented neoantigens drive type 1 diabetes and other autoimmune diseases?

Authors:  Philippa Marrack; John W Kappler
Journal:  Cold Spring Harb Perspect Med       Date:  2012-09-01       Impact factor: 6.915

9.  T cell receptor signaling is limited by docking geometry to peptide-major histocompatibility complex.

Authors:  Jarrett J Adams; Samanthi Narayanan; Baoyu Liu; Michael E Birnbaum; Andrew C Kruse; Natalie A Bowerman; Wei Chen; Aron M Levin; Janet M Connolly; Cheng Zhu; David M Kranz; K Christopher Garcia
Journal:  Immunity       Date:  2011-11-23       Impact factor: 31.745

10.  A single T cell receptor bound to major histocompatibility complex class I and class II glycoproteins reveals switchable TCR conformers.

Authors:  Lei Yin; Eric Huseby; James Scott-Browne; Kira Rubtsova; Clamencia Pinilla; Frances Crawford; Philippa Marrack; Shaodong Dai; John W Kappler
Journal:  Immunity       Date:  2011-06-16       Impact factor: 31.745

View more
  18 in total

Review 1.  The quest for better understanding of HLA-disease association: scenes from a road less travelled by.

Authors:  Joseph Holoshitz
Journal:  Discov Med       Date:  2013-09       Impact factor: 2.970

Review 2.  Human Leukocyte Antigen-Disease Associations in Rheumatoid Arthritis.

Authors:  Vincent van Drongelen; Joseph Holoshitz
Journal:  Rheum Dis Clin North Am       Date:  2017-08       Impact factor: 2.670

Review 3.  Molecules in medicine mini review: the αβ T cell receptor.

Authors:  Eric T Clambey; Bennett Davenport; John W Kappler; Philippa Marrack; Dirk Homann
Journal:  J Mol Med (Berl)       Date:  2014-05-22       Impact factor: 4.599

4.  Metal-triggered conformational reorientation of a self-peptide bound to a disease-associated HLA-B*27 subtype.

Authors:  Ronja Driller; Martin Ballaschk; Peter Schmieder; Barbara Uchanska-Ziegler; Andreas Ziegler; Bernhard Loll
Journal:  J Biol Chem       Date:  2019-07-11       Impact factor: 5.157

Review 5.  Thinking bedside at the bench: the NOD mouse model of T1DM.

Authors:  James C Reed; Kevan C Herold
Journal:  Nat Rev Endocrinol       Date:  2015-01-27       Impact factor: 43.330

6.  Analysis of self-antigen specificity of islet-infiltrating T cells from human donors with type 1 diabetes.

Authors:  Jenny Aurielle B Babon; Megan E DeNicola; David M Blodgett; Inne Crèvecoeur; Thomas S Buttrick; René Maehr; Rita Bottino; Ali Naji; John Kaddis; Wassim Elyaman; Eddie A James; Rachana Haliyur; Marcela Brissova; Lut Overbergh; Chantal Mathieu; Thomas Delong; Kathryn Haskins; Alberto Pugliese; Martha Campbell-Thompson; Clayton Mathews; Mark A Atkinson; Alvin C Powers; David M Harlan; Sally C Kent
Journal:  Nat Med       Date:  2016-10-31       Impact factor: 53.440

Review 7.  Enzymatic Transition States and Drug Design.

Authors:  Vern L Schramm
Journal:  Chem Rev       Date:  2018-10-18       Impact factor: 60.622

Review 8.  A reciprocal HLA-Disease Association in Rheumatoid Arthritis and Pemphigus Vulgaris.

Authors:  Vincent Van Drongelen; Joseph Holoshitz
Journal:  Front Biosci (Landmark Ed)       Date:  2017-01-01

9.  Coreceptor scanning by the T cell receptor provides a mechanism for T cell tolerance.

Authors:  Ondrej Stepanek; Arvind S Prabhakar; Celine Osswald; Carolyn G King; Anna Bulek; Dieter Naeher; Marina Beaufils-Hugot; Michael L Abanto; Virginie Galati; Barbara Hausmann; Rosemarie Lang; David K Cole; Eric S Huseby; Andrew K Sewell; Arup K Chakraborty; Ed Palmer
Journal:  Cell       Date:  2014-10-02       Impact factor: 41.582

10.  Low-dose CDK4/6 inhibitors induce presentation of pathway specific MHC ligands as potential targets for cancer immunotherapy.

Authors:  Angel Charles; Christopher M Bourne; Tanya Korontsvit; Zita E H Aretz; Sung Soo Mun; Tao Dao; Martin G Klatt; David A Scheinberg
Journal:  Oncoimmunology       Date:  2021-05-24       Impact factor: 8.110

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.